Verdad Advisers’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$392K Buy
25,000
+2,500
+11% +$37.9K 0.52% 74
2024
Q2
$304K Hold
22,500
0.35% 110
2024
Q1
$623K Sell
22,500
-8,500
-27% -$189K 0.68% 60
2023
Q4
$597K Sell
31,000
-22,800
-42% -$413K 1.21% 28
2023
Q3
$869K Buy
+53,800
New +$955K 1.33% 18

Other funds holding ACH

Verdad Advisers's ACH Position: Q3 2024 in Review

Verdad Advisers increased its Accendra Health (ACH) stake by 11% in Q3 2024, buying an estimated $37.9K and bringing the position to 25,000 shares worth $392K. The position accounts for 0.52% of the portfolio, ranked #74.

Verdad Advisers first reported a position in ACH in Q3 2023 and has held it in 5 quarters since. The position peaked at $869K in Q3 2023. 214 funds tracked by Wall St. Rank hold ACH as of Q3 2024.

  • Verdad Advisers held 25,000 shares of Accendra Health worth $392K as of Q3 2024.
  • Verdad Advisers bought 2,500 Accendra Health shares in Q3 2024, an estimated $37.9K.
  • Accendra Health made up 0.52% of Verdad Advisers's portfolio in Q3 2024, its #74 holding.
  • Verdad Advisers first reported a position in Accendra Health in Q3 2023 and has held it in 5 quarters since.
  • Verdad Advisers's Accendra Health position peaked at $869K in Q3 2023.
  • 214 funds tracked by Wall St. Rank held Accendra Health as of Q3 2024.

Based on Verdad Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.